In January 2016 Alvimedica Participated in the Asia PCR in Singapore. Our participation included a symposium which details you can find below.
Objectives of the session:
Here below you can find the complete agenda and the details of the session.
Title: ‘Cre8™ DES in diabetics: when innovation in drug elution technology is translated into empowered efficacy’
Chairpersons: R. Mohd Ali, J. Fajadet
Agenda:
08:15 – 08:17 ‘Introduction to PCI challenges in diabetics’ – J. Fajadet
08:17 – 08:27 ‘How the innovative Amphilimus™ formulation eluted from Cre8™ empowers efficacy in diabetics’ – J. Tan
08:27 – 08:37 ‘The latest Cre8™ clinical evidence in diabetics confirms its enhanced efficacy in this cohort of patients’ – R. Mohd Ali
08:37 – 08:42 ‘Discussion and audience interaction’
08:42 – 08:45 ‘Take-home messages’ – J. Fajadet
